Winn RJ - Search Results

1

Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.

Dhingra HM, Murphy WK, Winn RJ, Raber MN, Hong WK. Dhingra HM, et al. Among authors: winn rj. Invest New Drugs. 1991 Feb;9(1):69-72. doi: 10.1007/BF00194548. Invest New Drugs. 1991. PMID: 1709153 Clinical Trial. No abstract available.

2

Phase II clinical trial of didemnin B in previously treated small cell lung cancer.

Shin DM, Holoye PY, Forman A, Winn R, Perez-Soler R, Dakhil S, Rosenthal J, Raber MN, Hong WK. Shin DM, et al. Invest New Drugs. 1994;12(3):243-9. doi: 10.1007/BF00873966. Invest New Drugs. 1994. PMID: 7896544 Review.

3

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma.

Fossella FV, Winn RJ, Holoye PY, Hallinan B, Raber MN, Hoelzer K, Young JA, Readling J, Bowers B, Hong WK. Fossella FV, et al. Among authors: winn rj. Invest New Drugs. 1992 Nov;10(4):331-5. doi: 10.1007/BF00944191. Invest New Drugs. 1992. PMID: 1336771 Clinical Trial.

4

Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma.

Fossella FV, Winn RJ, Holoye PY, Raber MN, Holden L, Belt R, Allen H, Hallinan B, Harper K. Fossella FV, et al. Among authors: winn rj. Invest New Drugs. 1991 Nov;9(4):375-6. doi: 10.1007/BF00183586. Invest New Drugs. 1991. PMID: 1666631 Clinical Trial. No abstract available.

5

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.

Dimery IW, Brooks BJ, Winn R, Martin T, Shirinian M, Hong WK. Dimery IW, et al. J Clin Oncol. 1991 Nov;9(11):1939-44. doi: 10.1200/JCO.1991.9.11.1939. J Clin Oncol. 1991. PMID: 1941052 Clinical Trial.

6

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, Davilla E, Leimert J, Dhingra H, Raber MN, et al. Murphy WK, et al. Among authors: winn rj. J Natl Cancer Inst. 1993 Mar 3;85(5):384-8. doi: 10.1093/jnci/85.5.384. J Natl Cancer Inst. 1993. PMID: 8094466 Clinical Trial.

7

Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK. Benner SE, et al. Among authors: winn rj. J Natl Cancer Inst. 1993 Jan 6;85(1):44-7. doi: 10.1093/jnci/85.1.44. J Natl Cancer Inst. 1993. PMID: 8416256 Clinical Trial.

8

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.

Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK. Huber MH, et al. Among authors: winn rj. Ann Oncol. 1995 Jan;6(1):83-5. doi: 10.1093/oxfordjournals.annonc.a059054. Ann Oncol. 1995. PMID: 7536031 Free article. Clinical Trial.

9

Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.

Benner SE, Wargovich MJ, Lippman SM, Fisher R, Velasco M, Winn RJ, Hong WK. Benner SE, et al. Among authors: winn rj. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):73-6. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8118389 Clinical Trial.

10

Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.

Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, Winn RJ, Fu KK, Cooper J, Spitz MR. Wu X, et al. Among authors: winn rj. J Natl Cancer Inst. 1998 Sep 16;90(18):1393-9. doi: 10.1093/jnci/90.18.1393. J Natl Cancer Inst. 1998. PMID: 9747870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters